TWST
Twist Bioscience Corporation · Healthcare · Medical - Diagnostics & Research
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham -2.6% · posisi baru bersih -5.6% · formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 4.77K | $725,583 | n/a | n/a |
| Q2 2026 | 113 | +8 | 54.74M | $5.63B | +14 | −6 |
| Q1 2026 | 108 | +15 | 51.20M | $2.43B | +20 | −5 |
| Q4 2025 | 92 | -2 | 51.46M | $1.63B | +1 | −3 |
| Q3 2025 | 18 | 0 | 32.97M | $927.70M | +1 | −2 |
| Q2 2025 | 16 | -3 | 28.73M | $1.06B | n/a | −3 |
| Q1 2025 | 16 | +1 | 15.75M | $618.44M | +2 | −1 |
| Q4 2024 | 15 | 0 | 15.20M | $706.21M | n/a | n/a |
| Q3 2024 | 14 | +1 | 11.38M | $514.14M | +2 | −1 |
| Q2 2024 | 13 | n/a | 12.61M | $621.59M | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management ✦ | 6.73M | +5.1% | $189.29M | 1.1% | ▲ Add | 6 | SEC ↗ |
| 2 | BlackRock ✦ (pasif) | 6.18M | -1.6% | $173.86M | 0.0% | ▼ Trim | 2 | SEC ↗ ×15 |
| 3 | The Vanguard Group ✦ (pasif) | 5.77M | -1.1% | $162.32M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 4 | State Street Global Advisors ✦ (pasif) | 3.09M | +23.5% | $86.93M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | JPMorgan Chase ✦ | 2.04M | n/a | $57.31M | 0.0% | n/c | 1 | SEC ↗ ×14 |
| 6 | Millennium Management ✦ | 1.79M | +151.6% | $50.48M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 7 | Goldman Sachs Group ✦ | 1.63M | n/a | $45.78M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 8 | Morgan Stanley ✦ | 1.49M | n/a | $41.99M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 9 | Geode Capital Management ✦ (pasif) | 1.45M | +1.7% | $40.76M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 10 | Baillie Gifford ✦ | 1.26M | +62.8% | $35.53M | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
| 11 | Point72 Asset Management ✦ | 530.03K | -75.4% | $14.92M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Wellington Management ✦ | 299.81K | -48.0% | $8.44M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 13 | Fidelity (FMR) ✦ | 219.53K | +1.1% | $6.18M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 14 | AQR Capital Management ✦ | 207.91K | +40.0% | $5.85M | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
| 15 | Citadel Advisors ✦ | 115.25K | -92.3% | $3.24M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 16 | Two Sigma Investments ✦ | 73.75K | -36.4% | $2.08M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 53.85K | +9.3% | $1.52M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 18 | Marshall Wace ✦ | 44.07K | Baru | $1.24M | 0.0% | New | 1 | SEC ↗ ×2 |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Marshall Wace | $1.24M | 0.0% |
Telah keluar
| Norges Bank | $737,382 | adalah 0.0% |
| Renaissance Technologies | $507,702 | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 279 pemegang, 76.80M saham, $3.56B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 2.46K lbr · $384,823
Officer, Director · 45 lbr · $9,336
Officer, Director · 146 lbr · $30,199
Officer, Director · 297 lbr · $61,116
Officer, Director · 290 lbr · $59,392
Officer, Director · 432 lbr · $87,958
Officer, Director · 1.02K lbr · $205,763
Officer, Director · 1.84K lbr · $368,806
Officer, Director · 481 lbr · $96,804
Officer · 25.71K lbr · $4.86M
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi